首頁 > 市場調查報告書 > 醫療設備

病患監測

市場調查報告書

商品編碼

2081258

NeuroSync市場預測（2034年）－按產品類型、技術、應用、最終用戶和地區分類的全球分析

NeuroSync Market Forecasts to 2034 - Global Analysis By Product Type, Technology, Application, End User and By Geography

出版日期: 2026年07月11日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

全球 NeuroSync 市場預計到 2026 年將達到 6 億美元，並在預測期內以 9.0% 的複合年成長率成長，到 2034 年達到 12 億美元。

NeuroSync是一個整合的神經技術平台，它結合了眼動追蹤分析、腦電圖（EEG）監測和人工智慧，用於評估、追蹤和最佳化大腦功能和認知表現。該系統能夠收集和分析即時神經和眼動數據，從而在各種應用情境中評估注意力、疲勞程度、腦震盪狀態和認知負荷。 NeuroSync技術包括一個內建感測器的穿戴式式頭戴裝置、一個軟體分析平台以及一個用於處理多模態生物訊號的雲端資料基礎設施。這項技術能夠客觀地測量以往只能透過專業臨床設備測量的腦健康指標，從而將神經診斷能力引入體育場館、軍事行動和消費者健康應用領域。

提高對運動中腦震蕩的認知

隨著人們對反覆頭部撞擊造成的長期神經系統影響的認知不斷提高，職業和業餘體育組織對客觀的腦震盪評估工具的需求日益成長。監管機構正在強制要求進行基準認知功能測試和傷後評估，而NeuroSync技術能夠有效率地提供這些服務。在運動員健康與安全方面，以證據為基礎的重返賽場決策正逐漸取代主觀症狀報告。保險和責任的考量也促使體育組織實施全面的腦健康監測計畫。家長對青少年體育運動安全性的擔憂，使得目標市場從職業聯賽擴展到教育機構。

資料隱私問題

收集和儲存詳細的神經學資料會引發嚴重的隱私問題，使商業部署和使用者接受度受到限制。腦部資料屬於高度敏感的個人訊息，可能影響就業、保險和法律訴訟。神經學資料保護的法律規範仍不完善，為開發者和使用者帶來合規的不確定性。跨境資料傳輸的限制限制了跨國部署中基於雲端的分析能力。消費者對科技公司資料安全措施的質疑也延伸到了神經技術應用領域。

消費者健康市場的擴張

消費者對最佳化個人健康的日益關注，為NeuroSync在臨床和運動領域之外的應用帶來了巨大的機會。穿戴式神經技術使用戶能夠透過便捷的消費級設備監測認知功能、壓力水平和睡眠品質。與健身和健康生態系統的整合，進一步拓展了市場，觸及更多注重健康的消費者。將腦部健康指標遊戲化，鼓勵用戶持續參與並收集數據。直接面對消費者的銷售模式繞過了傳統的醫療保健採購壁壘，加速了市場滲透。

對醫療設備的監管更加嚴格

NeuroSync產品宣稱具有診斷和治療功效，但面臨著日益嚴格的醫療設備法規，導致研發週期延長和合規成本上升。監管機構正在仔細審查基於演算法的評估方法與現有診斷方法相比的臨床有效性。將軟體歸類為醫療設備的要求給品管系統和文件編制帶來了負擔。國際監管協調尚未完成，進入全球市場需要經過多重核准流程。不利事件通報要求也為製造商帶來聲譽和法律風險。

新型冠狀病毒（COVID-19）的影響：

新冠疫情擾亂了體育賽事和臨床研究項目，而這些正是NeuroSync的關鍵應用領域，導致市場需求暫時下降。然而，這場危機加速了遠端醫療和遠端患者監護的普及，拓展了部署模式，使其超越了傳統框架。醫療服務提供者認知到遠距認知功能評估工具對於無法前往診所的患者的價值。即使在疫情結束後，結合線上和線下神經診斷服務的混合醫療模式也已確立。對韌性醫療基礎設施的重視，也推動了對分散式神經技術能力的持續投資。

在預測期內，眼動追蹤分析軟體領域預計將佔據最大的市場佔有率。

眼動追蹤分析軟體技術成熟，臨床有效性已得到證實，且與完整的神經影像系統相比，其實施成本相對較低，預計在預測期內將佔據最大的市場佔有率。眼動模式是認知負荷、疲勞和神經系統疾病的可靠指標，可支持多種應用。該領域的優勢在於其能夠與現有的顯示和攝影機基礎設施整合，從而降低了推廣門檻。研究機構和體育組織廣泛利用眼動追蹤進行運動表現最佳化和基準震盪篩檢。基於軟體的交付方式使其能夠面向大規模的用戶群體進行可擴展部署。

預計在預測期內，腦電圖整合部分將呈現最高的複合年成長率。

在預測期內，腦電圖（EEG）整合細分市場預計將呈現最高的成長率，這主要得益於醫療保健、研究和認知能力提升領域對即時腦活動監測和先進神經回饋應用日益成長的需求。腦電圖整合平台能夠精確捕捉神經訊號並產生可操作的洞察，這加速了其在腦機介面、心理健康解決方案和神經系統疾病管理中的應用。此外，穿戴式腦電圖設備、人工智慧訊號處理和雲端神經分析技術的進步，也提高了數據的準確性和適用性。對神經科學創新和個人化認知最佳化技術的投資增加，預計將進一步加速該細分市場在NeuroSync市場的擴張。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。這主要歸功於職業運動聯盟在運動員健康科技領域的大量投入，以及已確立的腦震盪訴訟推動了對客觀評估工具的投資。美國軍方開展了廣泛的戰備和創傷性腦損傷監測研究計畫。 NeuroSync Inc.、SyncThink 和 Tobii 等領先的神經技術公司總部均設在北美，並在那裡開展主要業務活動。腦健康科技的創業投資主要集中在波士頓、舊金山和其他主要科技中心。基於軟體的診斷工具的法律規範也相對完善。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。這主要得益於中國、印度和東南亞等地體育產業的擴張，以及西方標準運動員安全協議的日益普及。政府對神經科學研究和腦健康計畫的投入正在加速技術開發和商業化。日本和韓國人口老化推動了對認知功能監測和失智症預防應用的需求。該地區的製造能力使其能夠以低成本生產穿戴式神經技術硬體。電子競技產業的蓬勃發展也催生了針對職業玩家的注意力監測和表現監測等新應用。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 主要參與者（最多3家公司）的SWOT分析
區域分類
- 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
競爭性標竿分析
- 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第10章戰略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第11章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第12章：公司簡介

NeuroSync Inc.
SyncThink Inc.
Tobii AB
Smart Eye AB
BrainScope Company Inc.
Neural Analytics Inc.
Medtronic plc
Abbott Laboratories
GE HealthCare Technologies Inc.
Siemens Healthineers AG
Philips Healthcare
Microsoft Corporation
Meta Platforms Inc.
Magic Leap Inc.
EMOTIV Inc.
NeuroPace Inc.

簡介目錄圖表

Product Code: SMRC37739

According to Stratistics MRC, the Global NeuroSync Market is accounted for $0.6 billion in 2026 and is expected to reach $1.2 billion by 2034 growing at a CAGR of 9.0% during the forecast period. NeuroSync refers to integrated neurotechnology platforms that combine eye-tracking analytics, electroencephalography monitoring, and artificial intelligence to assess, track, and optimize brain function and cognitive performance. These systems capture and analyze real-time neural and ocular data to evaluate attention, fatigue, concussion status, and cognitive load across diverse applications. NeuroSync technology encompasses wearable headsets with embedded sensors, software analytics platforms, and cloud-based data infrastructure that process multimodal biometric signals. The technology enables objective measurement of brain health indicators that were previously accessible only through specialized clinical equipment, bringing neurodiagnostic capabilities to sports venues, military operations, and consumer wellness applications.

Market Dynamics:

Driver:

Sports concussion awareness

Growing recognition of long-term neurological consequences from repeated head impacts drives demand for objective concussion assessment tools across professional and amateur sports organizations. Regulatory bodies mandate baseline cognitive testing and post-injury evaluation protocols that NeuroSync technology efficiently delivers. Athlete health and safety initiatives prioritize evidence-based return-to-play decisions over subjective symptom reporting. Insurance and liability considerations compel sports organizations to implement comprehensive brain health monitoring programs. Parental concerns about youth sports safety expand addressable markets beyond professional leagues to educational institutions.

Restraint:

Data privacy concerns

Collection and storage of detailed neurological data raises significant privacy concerns that complicate commercial deployment and user adoption. Brain data represents highly sensitive personal information with potential implications for employment, insurance, and legal proceedings. Regulatory frameworks for neural data protection remain underdeveloped, creating compliance uncertainty for developers and users. Cross-border data transfer restrictions limit cloud-based analytics capabilities for multinational deployments. Consumer skepticism regarding data security practices of technology companies extends to neurotechnology applications.

Opportunity:

Consumer wellness market expansion

The growing consumer interest in personal health optimization creates substantial opportunities for NeuroSync applications beyond clinical and sports contexts. Wearable neurotechnology enables individuals to monitor cognitive performance, stress levels, and sleep quality through accessible consumer devices. Integration with fitness and wellness ecosystems expands market reach to health-conscious populations. Gamification of brain health metrics encourages sustained user engagement and data collection. Direct-to-consumer sales models bypass traditional healthcare procurement barriers and accelerate market penetration.

Threat:

Medical device regulatory scrutiny

NeuroSync products that make diagnostic or therapeutic claims face increasingly stringent medical device regulations that extend development timelines and increase compliance costs. Regulatory agencies scrutinize the clinical validity of algorithm-based assessments compared to established diagnostic methods. Software as a medical device classification requirements impose quality management systems and documentation burdens. International regulatory harmonization remains incomplete, necessitating multiple approval processes for global market access. Adverse event reporting requirements create reputational and legal exposure for manufacturers.

Covid-19 Impact:

The COVID-19 pandemic disrupted sports seasons and clinical research programs that represented primary NeuroSync application venues, temporarily reducing market demand. However, the crisis accelerated telehealth adoption and remote patient monitoring acceptance that expanded deployment models beyond traditional settings. Healthcare providers recognized the value of remote cognitive assessment tools for patients unable to visit clinics. Post-pandemic, hybrid care models persist that combine in-person and remote neurodiagnostic services. The emphasis on resilient healthcare infrastructure supports continued investment in distributed neurotechnology capabilities.

The eye-tracking analytics software segment is expected to be the largest during the forecast period

The eye-tracking analytics software segment is expected to account for the largest market share during the forecast period, due to mature technology with established clinical validation and relatively lower deployment costs compared to full neuroimaging systems. Eye movement patterns provide reliable indicators of cognitive load, fatigue, and neurological impairment that support diverse applications. The segment benefits from integration with existing display and camera infrastructure, reducing implementation barriers. Research institutions and sports organizations extensively utilize eye-tracking for performance optimization and concussion baseline testing. Software-based delivery enables scalable deployment across large user populations.

The EEG integration segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the EEG integration segment is predicted to witness the highest growth rate, driven by increasing demand for real-time brain activity monitoring and advanced neurofeedback applications across healthcare, research, and cognitive performance domains. The ability of EEG-integrated platforms to capture precise neural signals and generate actionable insights is accelerating adoption in brain-computer interfaces, mental wellness solutions, and neurological disorder management. Furthermore, advancements in wearable EEG devices, AI-powered signal processing, and cloud-based neuroanalytics are enhancing data accuracy and usability. Growing investments in neuroscience innovation and personalized cognitive optimization technologies are expected to further strengthen the segment's expansion within the NeuroSync Market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to concentrated professional sports leagues with substantial resources for athlete health technologies and established concussion litigation driving investment in objective assessment tools. The United States military maintains extensive research programs for combat readiness and traumatic brain injury monitoring. Leading neurotechnology companies including NeuroSync Inc., SyncThink, and Tobii maintain headquarters and primary operations in North America. Venture capital funding for brain health technology concentrates in Boston, San Francisco, and other major technology hubs. Regulatory frameworks for software-based diagnostic tools are relatively well-established.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to expanding sports industries in China, India, and Southeast Asia that increasingly adopt Western-standard athlete safety protocols. Government investment in neuroscience research and brain health initiatives accelerates technology development and commercialization. Aging populations in Japan and South Korea drive demand for cognitive monitoring and dementia prevention applications. Manufacturing capabilities in the region enable cost-effective production of wearable neurotechnology hardware. Growing esports industries create novel applications for attention and performance monitoring among professional gamers.

Key players in the market

Some of the key players in NeuroSync Market include NeuroSync Inc., SyncThink Inc., Tobii AB, Smart Eye AB, BrainScope Company Inc., Neural Analytics Inc., Medtronic plc, Abbott Laboratories, GE HealthCare Technologies Inc., Siemens Healthineers AG, Philips Healthcare, Microsoft Corporation, Meta Platforms Inc., Magic Leap Inc., EMOTIV Inc. and NeuroPace Inc..

Key Developments:

In May 2026, NeuroSync Inc. launched a next-generation wearable headset with integrated EEG and eye-tracking sensors capable of real-time cognitive load assessment for industrial safety applications.

In April 2026, Tobii AB expanded its eye-tracking analytics platform with AI-powered concussion detection algorithms validated through partnerships with major European football leagues.

In March 2026, SyncThink Inc. received FDA clearance for updated virtual reality-based ocular motor assessment tools designed for rapid sideline concussion evaluation in sports settings.

Product Types Covered:

Eye-Tracking Analytics Software
VR-Based Assessment Platforms
Wearable Neuro-Monitoring Devices
Cognitive Performance Platforms
Fatigue and Concussion Monitoring
Brain Health Assessment Tools

Technologies Covered:

Eye-Tracking Technology
EEG Integration
AI and Machine Learning Analytics
Virtual Reality
Cloud-Based Data Platforms

Applications Covered:

Sports Performance Optimization
Concussion Diagnosis and Management
Military and Defense
Clinical Neurodiagnostics
Cognitive Training
Research and Academia

End Users Covered:

Professional Sports Teams
Collegiate Athletics
Healthcare Providers
Military Organizations
Research Institutions
Consumer Wellness

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global NeuroSync Market, By Product Type

5.1 Eye-Tracking Analytics Software
5.2 VR-Based Assessment Platforms
5.3 Wearable Neuro-Monitoring Devices
5.4 Cognitive Performance Platforms
5.5 Fatigue and Concussion Monitoring
5.6 Brain Health Assessment Tools

6 Global NeuroSync Market, By Technology

6.1 Eye-Tracking Technology
6.2 EEG Integration
6.3 AI and Machine Learning Analytics
6.4 Virtual Reality
6.5 Cloud-Based Data Platforms

7 Global NeuroSync Market, By Application

7.1 Sports Performance Optimization
7.2 Concussion Diagnosis and Management
7.3 Military and Defense
7.4 Clinical Neurodiagnostics
7.5 Cognitive Training
7.6 Research and Academia

8 Global NeuroSync Market, By End User

8.1 Professional Sports Teams
8.2 Collegiate Athletics
8.3 Healthcare Providers
8.4 Military Organizations
8.5 Research Institutions
8.6 Consumer Wellness

9 Global NeuroSync Market, By Geography

9.1 North America
- 9.1.1 United States
- 9.1.2 Canada
- 9.1.3 Mexico
9.2 Europe
- 9.2.1 United Kingdom
- 9.2.2 Germany
- 9.2.3 France
- 9.2.4 Italy
- 9.2.5 Spain
- 9.2.6 Netherlands
- 9.2.7 Belgium
- 9.2.8 Sweden
- 9.2.9 Switzerland
- 9.2.10 Poland
- 9.2.11 Rest of Europe
9.3 Asia Pacific
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 South Korea
- 9.3.5 Australia
- 9.3.6 Indonesia
- 9.3.7 Thailand
- 9.3.8 Malaysia
- 9.3.9 Singapore
- 9.3.10 Vietnam
- 9.3.11 Rest of Asia Pacific
9.4 South America
- 9.4.1 Brazil
- 9.4.2 Argentina
- 9.4.3 Colombia
- 9.4.4 Chile
- 9.4.5 Peru
- 9.4.6 Rest of South America
9.5 Rest of the World (RoW)
- 9.5.1 Middle East
  - 9.5.1.1 Saudi Arabia
  - 9.5.1.2 United Arab Emirates
  - 9.5.1.3 Qatar
  - 9.5.1.4 Israel
  - 9.5.1.5 Rest of Middle East
- 9.5.2 Africa
  - 9.5.2.1 South Africa
  - 9.5.2.2 Egypt
  - 9.5.2.3 Morocco
  - 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

10.1 Industry Value Network and Supply Chain Assessment
10.2 White-Space and Opportunity Mapping
10.3 Product Evolution and Market Life Cycle Analysis
10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

11.1 Mergers and Acquisitions
11.2 Partnerships, Alliances, and Joint Ventures
11.3 New Product Launches and Certifications
11.4 Capacity Expansion and Investments
11.5 Other Strategic Initiatives

12 Company Profiles

12.1 NeuroSync Inc.
12.2 SyncThink Inc.
12.3 Tobii AB
12.4 Smart Eye AB
12.5 BrainScope Company Inc.
12.6 Neural Analytics Inc.
12.7 Medtronic plc
12.8 Abbott Laboratories
12.9 GE HealthCare Technologies Inc.
12.10 Siemens Healthineers AG
12.11 Philips Healthcare
12.12 Microsoft Corporation
12.13 Meta Platforms Inc.
12.14 Magic Leap Inc.
12.15 EMOTIV Inc.
12.16 NeuroPace Inc.

簡介目錄圖表

List of Tables

Table 1 Global NeuroSync Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global NeuroSync Market Outlook, By Product Type (2023-2034) ($MN)
Table 3 Global NeuroSync Market Outlook, By Eye-Tracking Analytics Software (2023-2034) ($MN)
Table 4 Global NeuroSync Market Outlook, By VR-Based Assessment Platforms (2023-2034) ($MN)
Table 5 Global NeuroSync Market Outlook, By Wearable Neuro-Monitoring Devices (2023-2034) ($MN)
Table 6 Global NeuroSync Market Outlook, By Cognitive Performance Platforms (2023-2034) ($MN)
Table 7 Global NeuroSync Market Outlook, By Fatigue and Concussion Monitoring (2023-2034) ($MN)
Table 8 Global NeuroSync Market Outlook, By Brain Health Assessment Tools (2023-2034) ($MN)
Table 9 Global NeuroSync Market Outlook, By Technology (2023-2034) ($MN)
Table 10 Global NeuroSync Market Outlook, By Eye-Tracking Technology (2023-2034) ($MN)
Table 11 Global NeuroSync Market Outlook, By EEG Integration (2023-2034) ($MN)
Table 12 Global NeuroSync Market Outlook, By AI and Machine Learning Analytics (2023-2034) ($MN)
Table 13 Global NeuroSync Market Outlook, By Virtual Reality (2023-2034) ($MN)
Table 14 Global NeuroSync Market Outlook, By Cloud-Based Data Platforms (2023-2034) ($MN)
Table 15 Global NeuroSync Market Outlook, By Application (2023-2034) ($MN)
Table 16 Global NeuroSync Market Outlook, By Sports Performance Optimization (2023-2034) ($MN)
Table 17 Global NeuroSync Market Outlook, By Concussion Diagnosis and Management (2023-2034) ($MN)
Table 18 Global NeuroSync Market Outlook, By Military and Defense (2023-2034) ($MN)
Table 19 Global NeuroSync Market Outlook, By Clinical Neurodiagnostics (2023-2034) ($MN)
Table 20 Global NeuroSync Market Outlook, By Cognitive Training (2023-2034) ($MN)
Table 21 Global NeuroSync Market Outlook, By Research and Academia (2023-2034) ($MN)
Table 22 Global NeuroSync Market Outlook, By End User (2023-2034) ($MN)
Table 23 Global NeuroSync Market Outlook, By Professional Sports Teams (2023-2034) ($MN)
Table 24 Global NeuroSync Market Outlook, By Collegiate Athletics (2023-2034) ($MN)
Table 25 Global NeuroSync Market Outlook, By Healthcare Providers (2023-2034) ($MN)
Table 26 Global NeuroSync Market Outlook, By Military Organizations (2023-2034) ($MN)
Table 27 Global NeuroSync Market Outlook, By Research Institutions (2023-2034) ($MN)
Table 28 Global NeuroSync Market Outlook, By Consumer Wellness (2023-2034) ($MN)